2025 Q3 #2: Festival of Genomics
The G2P team had fun meeting up with friends and colleagues after the 2025 Festival of Genomics & Biodata in Boston!
The G2P team had fun meeting up with friends and colleagues after the 2025 Festival of Genomics & Biodata in Boston!
‘DNA isn’t a crystal ball for every kind of illness’ but potential benefits outweigh fears, says geneticist, Robert C. Green, MD, MPH.
June 24, 2025 9:30-10am: (Panel) How is the genomics ecosystem responding to the current climate? Chairperson: Robert C. Green Speakers: Eric Green, Anthony Monaco, Stacey Gabriel 11:30am-1:00pm (Roundtable Discussion) Building inclusivity and trust in genomics Speakers: Anna Lewis, Angélica Torres-Berrío, Maria Chahrour 12:30-1:00pm: Using Million Veteran Program data to improve health care in the healthcare … Continued
Screening can now determine their risk for an ever-growing list of conditions — including ones we can’t do much about.
What if your DNA could help you avoid serious illnesses before they even start? In this episode of ‘Genetics for Healthcare,’ Rome Madison and Dr. Robert Green, medical geneticist at Harvard Medical School, discuss how cutting-edge genomics is transforming healthcare—from reactive to proactive.
The National Academy of Medicine (NAM) has selected 11 individuals for the 2025 class of the NAM Scholars in Diagnostic Excellence program. Funded by the Gordon and Betty Moore Foundation, this collaborative program in partnership with the Council of Medical Specialty Societies (CMSS) offers a one-year, part-time experience for exceptional health professionals to advance their diagnostic … Continued
More than a decade ago, researchers launched the BabySeq Project, a pilot program to return newborn genomic sequencing results to parents and measure the effects on newborn care. Today, over 30 international initiatives are exploring the expansion of newborn screening using genomic sequencing (NBSeq), but a new study by researchers from Mass General Brigham highlights … Continued
Robert C. Green, MD, MPH will present The Path to Universal Newborn Sequencing at Labroots’ 13th Annual Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2025, on May 14th at 10:00 AM PDT. Join to learn how early genomic insights are redefining the future of personalized and preventive medicine and why every newborn could benefit … Continued
Researchers hope the new list of identifiable conditions—treatable during or after pregnancy—will help families prepare for what’s ahead and give their babies the best possible start.
“The ability to diagnose and treat nearly 300 actionable genetic conditions in fetuses and newborns marks a significant milestone in modern medicine. From traditional heel stick tests to cutting-edge genomic sequencing, these advances empower families with critical information and life-saving options. As research continues to evolve, integrating these technologies into routine prenatal and neonatal care … Continued
G2P Director, Dr. Robert Green, takes the main stage at TED to discuss the promise of genome sequencing at birth
“We saw a critical gap in prenatal care and an opportunity to define the genetic disorders that are treatable during this time,” said senior author Nina Gold, director of Prenatal Medical Genetics at Massachusetts General Hospital and an assistant professor of pediatrics at Harvard Medical School. “These conditions are actionable — meaning that, empowered with … Continued
Researchers from Mass General Brigham, Harvard Medical School and Duke University School of Medicine have identified nearly 300 genetic disorders that can be treated before or immediately after a baby is born. This “treatable fetal findings list” could improve the diagnosis of genetic conditions in pregnancy and enhance the treatment options available for fetuses who have … Continued
Dr. Robert C. Green joined Dr. Amy Ponte, Dr. Stephen Kingsmore, Dr. Wendy Chung, and Natasha Bonhomme to discuss the promise of newborn screening by genome sequencing to reduce the diagnostic odyssey at the Sanofi Rare Medical Forum.
March 20, 2025 – In-Person Platform Presentation: International Consortium on Newborn Sequencing (ICoNS) Consensus Guidelines for Gene Selection in Genomic Newborn Screening Programs presented by Julie Yeo on behalf of Dr. Nina Gold March 21, 2025 – Virtual Platform Presentation: A Genotype-first Approach Among Adults at Risk for Treatable Monogenic Disorders Reveals Underdiagnosis and Incomplete … Continued
Robert C. Green, MD, MPH will be taking the main stage at TED in Vancouver, Canada for TED: Humanity Reimagined. His talk will address the promise of genomic screening in infants and draw on 10 years of experience with the BabySeq Project.
Robert C. Green, MD, MPH will give a keynote address on Scaling Genomic Medicine: Transforming Newborn Screening through Informatics and Innovation at the Bio-IT World Conference & Expo. This talk will explore the groundbreaking progress in genomic medicine, featuring real-world stories of families impacted by these discoveries in the BabySeq Project.
Robert C. Green, MD, MPH will present “From Genomes & MultiOmes to Proactive Health” at NextMed Health 2025. This year’s NextMed Health is focused on re-imagining the future of health and medicine.
NextGen Omics & Spatial Biology connects thought leaders, researchers, and experts with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics. Robert C. Green, MD, MPH will unveil results from the BabySeq Project in his opening keynote address on The Path to Universal Newborn Sequencing and explore how universal sequencing … Continued
BabySeq is everywhere! This G2P newsletter highlights several upcoming speaking engagements where G2P team members and collaborators will be presenting on the latest newborn sequencing research. Nina Gold, MD and Julie Yeo will be presenting on their recent work at ACMG 2025 in LA. Robert C. Green, MD, MPH will be speaking at NextMed Health, … Continued
José Manuel González de Aledo Castillo, PhD reflects on his experience rotating with the Genomes2People research program and working on the BabySeq project for a year as part of the IFCC Professional Exchange Program (PSEP). During his rotation, he supported recruitment, genomic analysis, and return of results for the BabySeq project. He also presented results … Continued
The National Human Genome Research Institute (NHGRI) Center for Precision Health Research (CPHR) sponsors a monthly series of talks by intramural and special speakers on research relevant to the use of genomic data and large-scale electronic health record information to improve health. In this seminar, Dr. Nina Gold gives a talk on the identification of … Continued
Over the past decade, genomic sequencing has become a tool for understanding the genetic underpinnings of sonographic abnormalities detected during pregnancy. However, many genetic conditions do not cause detectable physical changes, but can still have profound implications for the health of the fetus or newborn. In this talk, Dr. Gold will discuss a proposed framework … Continued
Thanks to you, we made it happen! Extending a heartfelt thank you for your support of the Genomes2People Research Program in 2024. This newsletter highlights milestones in 2024, including expanding the BabySeq project to 7 sites nationwide, hosting 15 research trainees, contributing to a successful International Conference on Newborn Sequencing, and completing the first ever … Continued
Robert Green, MD, MPH was interviewed by Gulf Times at the recent Precision Medicine and the Future of Genomics (PMFG) Summit in Doha, Qatar. Dr. Green discusses findings from the BabySeq Project and the potential for Qatar to be leader in genomics and precision medicine.
Robert C. Green, MD, MPH and Nicolas Encina, MS, MBA speak on genomic newborn screening at the 10th annual Precision Medicine and the Future of Genomics (PMFG) Summit. Dr. Green gave the opening keynote entitled “The Path to Lifelong Genomic Medicine.” Tuesday, December 3 9:00 – 9:10am: Global Advancements In Genomic Newborn Screening Introduction: Nicolas … Continued
Dr. Robert Green speaks on the case for the universal sequencing of newborns at the European Molecular Biology Laboratory – European Bioinformatics Institute (EMBL-EBI) workshop on genetic biomarkers in pharmaceutical development.
International experts in newborn genome sequencing came together at the third annual meeting of the International Consortium on Newborn Sequencing (ICoNS’24) co-hosted by ScreenPlus in New York City. The conference is directed by Nic Encina and co-chaired by Drs. Robert Green and David Bick. Featured Sessions: Panel: NBSeq in 3/5/10 Years Moderator: Dr. Robert Green … Continued
Bethany Zettler, MS, CGC is interviewed in this piece about direct-to-consumer genetic testing. “This is the first time in human history that we have access to our genetic data essentially at the push of a button,” says Zettler. This article dives into risks and benefits of at-home genetic testing, including issues of clinical significance, false … Continued
Robert Green, MD, MPH opened the Precision Child Health: From Technology to Translation conference in Toronto with a keynote talk on the case for universal child sequencing, drawing on new results from the BabySeq Project. This event was organized by the Hospital for Sick Children (SickKids), Nature, and Nature Medicine.